STADA Arzneimittel Stock

Equities

SAZ

DE0007251803

Pharmaceuticals

Delayed Xetra 5-day change 1st Jan Change
- EUR -.--% Intraday chart for STADA Arzneimittel -1.95% -8.87%
Manager TitleAgeSince
Chief Executive Officer 60 2018-08-31
Director of Finance/CFO - 2022-12-31
Chief Tech/Sci/R&D Officer 60 2014-12-31
Director TitleAgeSince
Director/Board Member 45 2014-06-03
Director/Board Member 68 2016-08-25
Chairman 74 2017-09-26
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-.--%-1.95% - - 5.73B
+0.39%+4.61%+8.74%+88.80% 46.46B
-0.52%+2.59%+25.71%+91.74% 27.59B
+0.98%-4.56%+31.19% - 18.04B
+0.52%+0.24%-1.76%+36.88% 13.58B
-0.58%-1.96%-10.24%+138.93% 10.22B
-.--%+0.14% - - 6.79B
+0.30%+0.30%+30.23%+103.39% 5.59B
-1.00%-0.21%-34.87%-44.96% 5.18B
-0.77%-0.58%+11.00%+44.82% 5.13B
Average -0.07%-0.32%+7.50%+65.66% 14.43B
Weighted average by Cap. +0.10%+1.01%+12.10%+80.46%
See all sector performances
Logo STADA Arzneimittel
STADA Arzneimittel AG (STADA) is a global pharmaceutical company that focuses on multisource products. It focuses on three core business segments: Generics offers drugs in the multisource product category, made from readily available, off-patent active ingredients; Brand-Name Products focuses on multisource products that are accessible without active ingredient research and are principally offered to the public in the non-prescription and self-medication product sectors, while Special Pharmaceuticals focuses on products with specific market entry barriers or specialized sales structures, including oncological drugs. STADA generics are sold by numerous subsidiaries in the respective national markets.
Employees
-
More about the company